Katodritou, Eirini
Kyrtsonis, Marie-Christine
Delimpasi, Sosana
Kyriakou, Despoina
Symeonidis, Argiris
Spanoudakis, Emmanouil
Vasilopoulos, Georgios
Anagnostopoulos, Achilles
Kioumi, Anna
Zikos, Panagiotis
Aktypi, Anthi
Briasoulis, Evangelos
Megalakaki, Aikaterini
Repousis, Panayiotis
Adamopoulos, Ioannis
Gogos, Dimitrios
Kotsopoulou, Maria
Pappa, Vassiliki
Papadaki, Eleni
Fotiou, Despoina
Nikolaou, Eftychia
Giannopoulou, Evlambia
Hatzimichael, Eleftheria
Giannakoulas, Nikolaos
Douka, Vassiliki
Kokoviadou, Kyriaki
Timotheatou, Despoina
Terpos, Evangelos
Funding for this research was provided by:
Genesis Pharma
Article History
Received: 25 January 2018
Accepted: 2 May 2018
First Online: 13 May 2018
Change Date: 26 June 2018
Change Type: Correction
Change Details: The original version of this article contained a mistake. The name of Eirini Katroditou should have been Eirini Katodritou. The original article has been corrected.
Compliance with ethical standards
:
: The study protocol complied with the Helsinki Declaration standards, as revised in 2008 and was approved by the Ethical Committee of the authors’ institutions.
: E.K. Genesis Pharma SA: research support/PI; Genesis Pharma SA; Amgen; Novartis Hellas S.A.C.I.; Janssen-Cilag SACI: honoraria; A.S. Actellion; Alexion; Amgen; Astellas; Bristol Myers Squibb; Demo; Enorasis; Genzyme/Sanofi; Genesis Pharma SA; Gilead Sciences Hellas; Janssen-Cilag SACI; MSD; Novartis Hellas S.A.C.I.; Pfizer; ProtonPharma; Roche Hellas; Takeda: research support; Actellion; Amgen; Bristol Myers Squibb; Genzyme/Sanofi; Genesis Pharma SA; Gilead Sciences Hellas; Janssen-Cilag SACI; Novartis Hellas S.A.C.I.; Pfizer; Takeda: speakers bureau; Abbvie; Alexion; Amgen; Bristol Myers Squibb; Genzyme/Sanofi; Genesis Pharma SA; Gilead Sciences Hellas; MSD; Novartis Hellas S.A.C.I.; Pfizer; Roche Hellas; Takeda: advisory board G.V. Genesis Pharma SA; Gilead Sciences Hellas: research support; Bristol Myers Squibb; ARIAD; JUNO; Seattle Genetics: stockholder; GSK; Teva; Astellas; Bristol Myers Squibb; Gilead Sciences Hellas; Amgen: speakers bureau; Bristol Myers Squibb; Amgen; Janssen-Cilag SACI; Novartis Hellas S.A.C.I.; Genesis Pharma SA, Roche Hellas: advisory board; A.A. Genesis Pharma SA: honoraria; A.M. Genesis Pharma SA: research support/PI; Novartis Hellas S.A.C.I.; MSD; Pfizer; Glaxo: advisory board; E.H. Genesis Pharma, SA; Amgen; Abbvie; Janssen-Cilag SACI; Gilead Sciences Hellas; Novartis Hellas S.A.C.I.; Bristol Myers Squibb; Roche Hellas: honoraria and scientific advisory board, D.T. is employee of Genesis Pharma SA; E.T. Genesis Pharma SA; Amgen; Janssen-Cilag SACI: research support/PI; Genesis Pharma SA; Amgen; Janssen-Cilag SACI; Takeda; Bristol Myers Squibb: honoraria and scientific advisory board;, M-C.K., S.D., D.K., E.S., A.K., P.Z., A.A., E.BSuperscript removed., P.R., I.A., D.G., M.K., V.P., E.P., D.F., E.N., E.G., N.G., V.D., K.K.: nothing to disclose.